Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia
Conditions:   Pneumonia, Bacterial;   Community-acquiredInterventions:   Drug: Ceftaroline;   Drug: LevofloxacinSponsors:   Gary E. Stein, Pharm.D.;   Forest LaboratoriesCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2012 Category: Research Source Type: clinical trials

Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia
Conditions:   Pneumonia, Bacterial;   Community-acquiredInterventions:   Drug: Ceftaroline;   Drug: LevofloxacinSponsors:   Michigan State University;   Gary E. Stein, Pharm.D.;   Forest LaboratoriesRecruiting - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2012 Category: Research Source Type: clinical trials

A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia
Conditions:   Community-Acquired Bacterial Pneumonia;   Lung Infection of Individual Not Recently HospitalizedInterventions:   Drug: Ceftaroline;   Drug: CeftriaxoneSponsors:   AstraZeneca;   Forest LaboratoriesCompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2011 Category: Research Source Type: clinical trials